CR20110619A - Produccion recombinante de peptidos - Google Patents

Produccion recombinante de peptidos

Info

Publication number
CR20110619A
CR20110619A CR20110619A CR20110619A CR20110619A CR 20110619 A CR20110619 A CR 20110619A CR 20110619 A CR20110619 A CR 20110619A CR 20110619 A CR20110619 A CR 20110619A CR 20110619 A CR20110619 A CR 20110619A
Authority
CR
Costa Rica
Prior art keywords
peptides
recombinant production
precursor proteins
assembled
self
Prior art date
Application number
CR20110619A
Other languages
English (en)
Inventor
Daniel Huemmerich
Burghard Liebmann
Markus Fehr
Carsten Schwalb
Heike Brueser
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of CR20110619A publication Critical patent/CR20110619A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Proteinas precursoras repetitivas autoensambladas secuencias de ácidos nucleicos y constructos de expresión que los codifican, y métodos para la producción recombinante de péptidos mediante el uso de dichas proteinas precursoras
CR20110619A 2009-06-03 2011-11-23 Produccion recombinante de peptidos CR20110619A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09161837 2009-06-03

Publications (1)

Publication Number Publication Date
CR20110619A true CR20110619A (es) 2012-02-09

Family

ID=43298234

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110619A CR20110619A (es) 2009-06-03 2011-11-23 Produccion recombinante de peptidos

Country Status (20)

Country Link
US (1) US9481719B2 (es)
EP (1) EP2437769B1 (es)
JP (1) JP5730293B2 (es)
KR (2) KR101834018B1 (es)
CN (1) CN102724992B (es)
AR (1) AR076977A1 (es)
AU (1) AU2010255732B8 (es)
BR (1) BRPI1011144B8 (es)
CA (1) CA2763626A1 (es)
CL (1) CL2011003075A1 (es)
CR (1) CR20110619A (es)
EC (1) ECSP12011577A (es)
ES (1) ES2763168T3 (es)
IL (1) IL216619A0 (es)
MX (1) MX2011012906A (es)
NZ (2) NZ615847A (es)
PE (1) PE20121033A1 (es)
RU (1) RU2548815C2 (es)
TW (1) TWI429750B (es)
WO (1) WO2010139736A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008531506A (ja) * 2005-02-24 2008-08-14 ザ ユニバーシティー オブ クイーンズランド ペプチドネットワーク
WO2012079125A1 (en) * 2010-12-14 2012-06-21 The University Of Queensland Designed biosurfactants, their manufacture, purification and use
CN103740659B (zh) * 2012-05-10 2015-06-03 江南大学 一种提高酶热稳定性的方法
CN103740662B (zh) * 2012-05-10 2015-08-19 江南大学 一种提高酶热稳定性的方法
CN103740661B (zh) * 2012-05-10 2015-06-03 江南大学 一种提高酶热稳定性的方法
US9976133B2 (en) 2012-06-20 2018-05-22 The Regents Of The University Of California Synzymes
CN104755502B (zh) * 2012-10-12 2018-05-18 清华大学 多肽的产生和纯化方法
WO2017055587A1 (de) * 2015-10-01 2017-04-06 Basf Se Rekombinante herstellung von peptiden
KR101970875B1 (ko) * 2017-05-10 2019-04-19 건국대학교 산학협력단 글루탐산 치환을 통해 항균 효과를 증진시킨 항생 펩타이드 및 이의 용도
KR101976923B1 (ko) * 2017-05-10 2019-05-10 건국대학교 산학협력단 D-루이신 치환을 통해 항균 효과를 증진시킨 항생 펩타이드 및 이의 용도
KR101970876B1 (ko) * 2017-05-10 2019-04-19 건국대학교 산학협력단 D-라이신 치환을 통해 항균 효과를 증진시킨 항생 펩타이드 및 이의 용도
CN106496307B (zh) * 2016-11-09 2019-11-01 湖南科技学院 一种新的抗菌肽及其用途
CN108503690B (zh) * 2017-02-28 2020-07-03 暨南大学 一种促进创伤后组织修复与再生的修复肽及其应用
US11260101B2 (en) 2017-02-28 2022-03-01 Jinan University Repair peptide for use in promoting post-traumatic tissue repair and regeneration, and application thereof
WO2020048996A1 (en) 2018-09-06 2020-03-12 ETH Zürich Self-assembling globular proteins and uses thereof
CN111388374B (zh) * 2020-04-11 2022-09-06 百草堂(湖北)制药有限公司 一种洗发露
WO2022155389A2 (en) 2021-01-14 2022-07-21 Biocatalyst Llc Compositions and methods for peptide production
CN116874613B (zh) * 2023-09-06 2023-11-17 南京华盖制药有限公司 一种广谱高效的抗菌多肽aph143及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504761D0 (en) 1995-03-09 1995-04-26 Unilever Plc Amphiphilic peptide and analogs thereof
KR100263583B1 (ko) * 1997-05-28 2000-08-01 박종헌 항균 펩타이드의 대량 제조방법 및 그에 유용한 플라즈미드 벡타
EP1131448A2 (en) * 1998-11-20 2001-09-12 Micrologix Biotech, Inc. Producing antimicrobial cationic peptides as fusion proteins
AU2002312426A1 (en) * 2001-06-06 2002-12-16 University Of Wyoming Expression of spider silk proteins in higher plants
KR100438416B1 (ko) 2001-09-19 2004-07-02 학교법인조선대학교 Ｃａ－ｍａ 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 ＋ 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물
ES2275011T3 (es) 2001-11-20 2007-06-01 Novozymes A/S Polpeptidos antimicrobianos de pseudoplectania nigrella.
US20030219854A1 (en) 2002-03-21 2003-11-27 Micrologix Biotech Inc. Methods for producing modified anti-infective peptides
DE60329382D1 (de) 2002-04-22 2009-11-05 Dow Global Technologies Inc Kostengünstige herstellung von peptiden
JP2006521355A (ja) 2003-03-17 2006-09-21 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア・センター・フオー・テクノロジー・トランスフアー 表面的に両親媒性のポリマー及びオリゴマーならびにそれらの使用
CA2573780C (en) 2004-07-22 2013-11-19 Technische Universitaet Muenchen Recombinant spider silk proteins
CA2619917C (en) 2005-08-29 2013-04-23 Technische Universitaet Muenchen Modified spider silk proteins
US7709227B2 (en) 2006-01-04 2010-05-04 Phasebio Pharmaceuticals, Inc. Multimeric ELP fusion constructs
CN101370481A (zh) 2006-01-20 2009-02-18 巴斯夫欧洲公司 两性自组装蛋白质在配制低水溶性的有效物质中的用途
JP2010524508A (ja) * 2007-04-27 2010-07-22 ダウ グローバル テクノロジーズ インコーポレイティド 可溶性組換え二十面体ウイルス様粒子の生産及びインビボ組織化の改善
CN101855239B (zh) 2007-06-20 2013-11-06 巴斯夫欧洲公司 合成的重复蛋白及其生产和用途
WO2009080306A1 (en) 2007-12-21 2009-07-02 Basf Se Anti-dandruff compositions containing peptides

Also Published As

Publication number Publication date
CL2011003075A1 (es) 2012-06-29
TW201103981A (en) 2011-02-01
AU2010255732B2 (en) 2013-09-12
JP5730293B2 (ja) 2015-06-10
MX2011012906A (es) 2012-02-01
NZ596735A (en) 2013-10-25
RU2548815C2 (ru) 2015-04-20
AU2010255732B8 (en) 2014-03-13
US9481719B2 (en) 2016-11-01
KR101834018B1 (ko) 2018-03-05
EP2437769A2 (de) 2012-04-11
BRPI1011144B1 (pt) 2021-02-02
ECSP12011577A (es) 2012-02-29
CN102724992B (zh) 2016-05-18
PE20121033A1 (es) 2012-08-02
BRPI1011144A2 (pt) 2016-10-25
ES2763168T3 (es) 2020-05-27
US20120088268A1 (en) 2012-04-12
CN102724992A (zh) 2012-10-10
AR076977A1 (es) 2011-07-20
BRPI1011144B8 (pt) 2021-05-25
KR20140127344A (ko) 2014-11-03
CA2763626A1 (en) 2010-12-09
EP2437769B1 (de) 2019-09-25
TWI429750B (zh) 2014-03-11
KR20120014940A (ko) 2012-02-20
AU2010255732A1 (en) 2011-12-22
RU2011153757A (ru) 2013-07-20
WO2010139736A2 (de) 2010-12-09
KR101812842B1 (ko) 2017-12-27
AU2010255732A8 (en) 2014-03-13
WO2010139736A3 (de) 2011-03-10
JP2012528579A (ja) 2012-11-15
IL216619A0 (en) 2012-02-29
NZ615847A (en) 2014-11-28

Similar Documents

Publication Publication Date Title
CR20110619A (es) Produccion recombinante de peptidos
AR113177A2 (es) Polipéptidos que tienen actividad de lisozima y polinucleótidos que los codifican
CY1125029T1 (el) Τροποποιημενοι νουκλεοζιτες, νουκλεοτιδια, και νουκλεϊκα οξεα και χρησεις αυτων
MX2014005728A (es) Anticuerpos especificos para antigeno de la superficie celular de trofoblasto-2 y sus usos.
CR20110544A (es) Anticuerpo antagonista específico para el heterodímero de alfa-4-beta-7
AR122864A2 (es) Variantes de lipasa y polinucleótidos que las codifican
UY33578A (es) PÉPTIDO O COMPLEJO PEPTÍDICO QUE SE UNE A INTEGRINA a(ALFA) Y MÉTODOS Y USOS QUE IMPLICAN A LOS MISMOS
UY35456A (es) Moléculas de unión para bcma y cd3
CL2011001296A1 (es) Anticuerpo monoclonal capaz de inhibir la dimerizacion de cmet; acido nucleico, vector y celula huesped que comprenden las secuencias que codifican el anticuerpo; composicion que comprende el anticuerpo; uso del anticuerpo para inhibir el crecimiento y/o proliferacion de celulas tumorales.
CY1116987T1 (el) Συμπυκνωμενα ιμιδαζολυλιμιδαζολια ως αντιϊικες ενωσεις
BR112012011305A2 (pt) uso de uma proteína homóloga a uma proteína meab para aumentar a atividade enzimática de uma mutase do ácido 3-hidroxicarboxílico-coa
BR112014026308A8 (pt) meios de cultura celular, seu método de cultura, polipeptídeo, seu método de produção e seu uso, composições farmacêutica, e kit
MX2013012844A (es) Secuencias de aminoacidos dirigidas contra il-17a, il-17f y/o il-17a/f y polipeptidos que comprenden las mismas.
CL2015000757A1 (es) Una proteina
BR112015013525A2 (pt) método para produção de uma proteína de fusão, bem como composição compreendendo uma proteína de fusão
BR112012008173A2 (pt) molécula de ligação específica de rsv
BR112013014457A2 (pt) método com base em mgmt para obter alta produção de expressão de proteína recombinante
BR112012015740A2 (pt) anticorpos de anti-flt3 e metodos de uso dos mesmos
UY34343A (es) Proteinas de unión al antígeno cd27l
EA201391254A1 (ru) Способ получения агонистов гуанилатциклазы c
CL2012000886A1 (es) Polipeptido que comprende dos secuencias aminoacidas que permiten la union especifica al receptor para productos finales de glicosilacion avanzada (rpfga); uno o mas acidos nucleicos que codifican el polipeptido; celula; composicion; metodo para diagnosticar enfermedad o trastorno con rpfga.
MX2011006301A (es) Produccion de alcoholes de cadena ramificada por medio de microorganismos fotosinteticos.
BR112015000982B8 (pt) Método para a obtenção de uma molécula de ácido nucleico sintético
BR112016006606A2 (pt) Molécula de ácido nucléico recombinante, molécula de aminoácido recombinante, construção de expressão recombinante, vetor recombinante, micro-organismo recombinante, composição, método de produção de aminoácidos, uso de uma molécula de ácido nucléico e processo de produção fermentativa
GB201214580D0 (en) Benzocyanine compounds